Recent advance of spleen tyrosine kinase in diseases and drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advance of spleen tyrosine kinase in diseases and drugs

Published:2021-01 Issue: Volume:90 Page:107168
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Shao Yuxin,Zhang Su,Zhang Yanfen,Liu Zhongcheng

Funder

Natural Science Foundation of Hebei Province

Hebei Provincial Key Research Projects

Hebei University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference72 articles.

1. Hematopoietic or osteoclast-specific deletion of SYK leads to increased bone mass in experimental mice;Csete;Front Immunol.,2019

2. Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia;Bartaula-Brevik;Expert Opin. Investig. Drugs,2018

3. Elevated level of circulatorysTLT1 induces inflammation through SYK/MEK/ERK signalling in coronaryartery disease;Das;FASEB J.,2019

4. Modulation of BCR signaling by the induced dimerization of receptor-associated SYK;Westbroek;Antibodies,2017

5. Role of spleen tyrosine kinase in liver diseases;Kurniawan;World J. Gastroenterol.,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascites-derived EpCAM+/CD45+ ovarian cancer stem cells unveil potential therapeutic targets;2024-08-26

2. Yiqi Kaimi prescription regulates protein phosphorylation to promote intestinal motility in slow transit constipation;Journal of Ethnopharmacology;2024-07

3. Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors;SAR and QSAR in Environmental Research;2024-04-02

4. Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK);Bioorganic & Medicinal Chemistry;2023-12

5. Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis;Cellular and Molecular Life Sciences;2023-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3